InsiderTrades.com logo
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
From Autonomix   |   Ad
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

NSCI Insider Trading

Insider Ownership Percentage: 39.55%
Insider Buying (Last 12 Months): £15,000
Insider Selling (Last 12 Months): GBX 0

NetScientific Insider Trading History Chart

This chart shows the insider buying and selling history at NetScientific by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

NetScientific Share Price & Price History

Current Price: GBX 61.30
Price Change: ▼ Price Decrease of -1.7 (-2.70%)
As of 12/11/2023 08:50 AM ET

This chart shows the closing price history over time for NSCI up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
U.S. Military Defense Fails Without Vanadium?
From Edge On The Street   |   Ad
The metal vanadium is needed for numerous military applications, including jet engines, airframes, and ballistic missiles.

And although the U.S. Govt. considers vanadium critical to national security, less than 5% of the metal is mined in America. This means we're at the mercy of China and Russia for our supply.
See how this risky situation could light a fire

NetScientific Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/6/2023Jonathan RobinsonInsiderBuy25,000GBX 60£15,000
7/15/2021John ClarksonInsiderBuy10,000GBX 101£10,100
See Full Table
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
From Autonomix   |   Ad
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for NetScientific (LON:NSCI)

4.42% of NetScientific stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

NetScientific logo
NetScientific plc (AIM: NSCI) is a deep tech and life sciences VC investment group with an international portfolio of innovative companies. NetScientific identifies, invests in, and builds high growth companies in the UK and internationally. The company adds value through the proactive management of its portfolio, progressing to key value inflection points, and delivering investment returns through partial or full liquidity events. NetScientific differentiates itself by employing a capital-light investment approach, making judicial use of its balance sheet and syndicating investments through its wholly owned VC subsidiary, EMV Capital. The group secures a mixture of direct equity stakes and carried interest stakes in its portfolio of companies, creating a lean structure that can support a large portfolio. NetScientific is headquartered in London, United Kingdom, and is admitted to trading on AIM, a market operated by the London Stock Exchange.
Read More on NetScientific

Today's Range

Now: GBX 61.30
Low: 61.11
High: 61.30

50 Day Range

MA: GBX 59.40
Low: 49
High: 66

52 Week Range

Now: GBX 61.30
Low: 48
High: 88

Volume

1,349 shs

Average Volume

39,476 shs

Market Capitalization

£14.45 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.6

Who are the company insiders with the largest holdings of NetScientific?

NetScientific's top insider shareholders include:
  1. Jonathan Robinson (Insider)
Learn More about top insider investors at NetScientific.
How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology
From Autonomix   |   Ad
Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com
Invest in Autonomix today.